Presentation, prognosis and outcome of IgA nephropathy in Indian adults

Background:  IgA nephropathy (IgAN) is not well characterized in India. This retrospective study of 478 patients with IgAN was performed to clarify the presenting features, prognostic factors and the renal survival rates of the disease. Methods:  Three hundred and forty‐seven patients who had been f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nephrology (Carlton, Vic.) Vic.), 2005-10, Vol.10 (5), p.496-503
Hauptverfasser: CHACKO, BOBBY, JOHN, GEORGE T, NEELAKANTAN, NITHYA, KORULA, ANILA, BALAKRISHNAN, NARASIMHAN, KIRUBAKARAN, MESHACH G, JACOB, CHAKKO K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 503
container_issue 5
container_start_page 496
container_title Nephrology (Carlton, Vic.)
container_volume 10
creator CHACKO, BOBBY
JOHN, GEORGE T
NEELAKANTAN, NITHYA
KORULA, ANILA
BALAKRISHNAN, NARASIMHAN
KIRUBAKARAN, MESHACH G
JACOB, CHAKKO K
description Background:  IgA nephropathy (IgAN) is not well characterized in India. This retrospective study of 478 patients with IgAN was performed to clarify the presenting features, prognostic factors and the renal survival rates of the disease. Methods:  Three hundred and forty‐seven patients who had been followed on average for 27 months after diagnosis were divided into two groups based on renal function at diagnosis. In group 1 (229 patients), the creatinine clearance estimated by the Modification of Diet in Renal Disease formula was
doi_str_mv 10.1111/j.1440-1797.2005.00445.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68683652</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20794281</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5015-ee1143433d565e9102bf8fcee7722d9f065ecde5a6e880ae186f0acaeebd68863</originalsourceid><addsrcrecordid>eNqNkE1PGzEQhi1UBDTwF5BPnLrbsb32OhIXitI0AvEhURVxsZzd2WTDxk7Xu2ry7-s0ERyLLx7Z7zMzegihDFIWz9dFyrIMEpYP85QDyBQgy2S6PiAnbx-fYi04JFJIfUw-h7AAYDlX7IgcM8U5Y8BPyPihxYCus13t3Re6av3M-VAHal1Jfd8VfonUV3Qyu6IOV_PWr2w339Da0Ykra-uoLfumC6fksLJNwLP9PSA_v4-ern8kt_fjyfXVbVJIYDJBZCwTmRClVBKHcYVppasCMc85L4cVxNeiRGkVag0WmVYV2MIiTkultRIDcrHrGzf93WPozLIOBTaNdej7YJRWWijJ_xvkkA8zrlkM6l2waH0ILVZm1dZL224MA7O1bRZmK9VspZqtbfPPtllH9Hw_o58usXwH93pj4HIX-FM3uPlwY3M3eohFxJMdXocO12-4bV-NykUuza-7sXnJXm6-waMwz-IvPDycnw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20794281</pqid></control><display><type>article</type><title>Presentation, prognosis and outcome of IgA nephropathy in Indian adults</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>CHACKO, BOBBY ; JOHN, GEORGE T ; NEELAKANTAN, NITHYA ; KORULA, ANILA ; BALAKRISHNAN, NARASIMHAN ; KIRUBAKARAN, MESHACH G ; JACOB, CHAKKO K</creator><creatorcontrib>CHACKO, BOBBY ; JOHN, GEORGE T ; NEELAKANTAN, NITHYA ; KORULA, ANILA ; BALAKRISHNAN, NARASIMHAN ; KIRUBAKARAN, MESHACH G ; JACOB, CHAKKO K</creatorcontrib><description>Background:  IgA nephropathy (IgAN) is not well characterized in India. This retrospective study of 478 patients with IgAN was performed to clarify the presenting features, prognostic factors and the renal survival rates of the disease. Methods:  Three hundred and forty‐seven patients who had been followed on average for 27 months after diagnosis were divided into two groups based on renal function at diagnosis. In group 1 (229 patients), the creatinine clearance estimated by the Modification of Diet in Renal Disease formula was &lt;85 mL/min and in group 2 (118 patients) it was ≥85 mL/min. Results:  The predominant modes of presentation were nephrotic syndrome, hypertension and renal failure. Twenty‐nine percent of patients had more than a 20% decline in renal function at the last follow up. Multivariate analyses with stepwise logistic regression identified hypertension (odds ratio (OR) 3.5), nephrotic range proteinuria (OR 3.4) and sclerosed glomeruli on biopsy (OR 4.1) to be independently associated with progression in group 1 and hypertension (OR 2.3) in group 2. Seventeen percent of patients progressed to end‐stage renal disease (ESRD). Using multivariate analysis by the Cox model, four risk factors for developing ESRD were identified: hypertension (hazard ratio (HR) 3.1); nephrotic proteinuria (HR 1.9); interstitial fibrosis (HR 2.5); and sclerosed glomeruli (HR 1.8). The renal survival rates at 1, 5 and 10 years were 84, 55 and 33%, respectively, with a median renal survival of 61 months from the time of biopsy. Conclusion:  The relatively rapid rate of progression of IgAN in India is suggestive towards a ‘malignant’ nature of the disease in this country.</description><identifier>ISSN: 1320-5358</identifier><identifier>EISSN: 1440-1797</identifier><identifier>DOI: 10.1111/j.1440-1797.2005.00445.x</identifier><identifier>PMID: 16221102</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Science Pty</publisher><subject>Adolescent ; Adult ; Aged ; Creatinine - metabolism ; Disease Progression ; Female ; Follow-Up Studies ; Glomerulonephritis, IGA - mortality ; Humans ; IgA nephropathy ; India - epidemiology ; Kidney Failure, Chronic - mortality ; Logistic Models ; Male ; Middle Aged ; Multivariate Analysis ; Prognosis ; progression ; Retrospective Studies ; Risk Factors ; survival ; Survival Rate</subject><ispartof>Nephrology (Carlton, Vic.), 2005-10, Vol.10 (5), p.496-503</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5015-ee1143433d565e9102bf8fcee7722d9f065ecde5a6e880ae186f0acaeebd68863</citedby><cites>FETCH-LOGICAL-c5015-ee1143433d565e9102bf8fcee7722d9f065ecde5a6e880ae186f0acaeebd68863</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1440-1797.2005.00445.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1440-1797.2005.00445.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16221102$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CHACKO, BOBBY</creatorcontrib><creatorcontrib>JOHN, GEORGE T</creatorcontrib><creatorcontrib>NEELAKANTAN, NITHYA</creatorcontrib><creatorcontrib>KORULA, ANILA</creatorcontrib><creatorcontrib>BALAKRISHNAN, NARASIMHAN</creatorcontrib><creatorcontrib>KIRUBAKARAN, MESHACH G</creatorcontrib><creatorcontrib>JACOB, CHAKKO K</creatorcontrib><title>Presentation, prognosis and outcome of IgA nephropathy in Indian adults</title><title>Nephrology (Carlton, Vic.)</title><addtitle>Nephrology (Carlton)</addtitle><description>Background:  IgA nephropathy (IgAN) is not well characterized in India. This retrospective study of 478 patients with IgAN was performed to clarify the presenting features, prognostic factors and the renal survival rates of the disease. Methods:  Three hundred and forty‐seven patients who had been followed on average for 27 months after diagnosis were divided into two groups based on renal function at diagnosis. In group 1 (229 patients), the creatinine clearance estimated by the Modification of Diet in Renal Disease formula was &lt;85 mL/min and in group 2 (118 patients) it was ≥85 mL/min. Results:  The predominant modes of presentation were nephrotic syndrome, hypertension and renal failure. Twenty‐nine percent of patients had more than a 20% decline in renal function at the last follow up. Multivariate analyses with stepwise logistic regression identified hypertension (odds ratio (OR) 3.5), nephrotic range proteinuria (OR 3.4) and sclerosed glomeruli on biopsy (OR 4.1) to be independently associated with progression in group 1 and hypertension (OR 2.3) in group 2. Seventeen percent of patients progressed to end‐stage renal disease (ESRD). Using multivariate analysis by the Cox model, four risk factors for developing ESRD were identified: hypertension (hazard ratio (HR) 3.1); nephrotic proteinuria (HR 1.9); interstitial fibrosis (HR 2.5); and sclerosed glomeruli (HR 1.8). The renal survival rates at 1, 5 and 10 years were 84, 55 and 33%, respectively, with a median renal survival of 61 months from the time of biopsy. Conclusion:  The relatively rapid rate of progression of IgAN in India is suggestive towards a ‘malignant’ nature of the disease in this country.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Creatinine - metabolism</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Glomerulonephritis, IGA - mortality</subject><subject>Humans</subject><subject>IgA nephropathy</subject><subject>India - epidemiology</subject><subject>Kidney Failure, Chronic - mortality</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Prognosis</subject><subject>progression</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>survival</subject><subject>Survival Rate</subject><issn>1320-5358</issn><issn>1440-1797</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE1PGzEQhi1UBDTwF5BPnLrbsb32OhIXitI0AvEhURVxsZzd2WTDxk7Xu2ry7-s0ERyLLx7Z7zMzegihDFIWz9dFyrIMEpYP85QDyBQgy2S6PiAnbx-fYi04JFJIfUw-h7AAYDlX7IgcM8U5Y8BPyPihxYCus13t3Re6av3M-VAHal1Jfd8VfonUV3Qyu6IOV_PWr2w339Da0Ykra-uoLfumC6fksLJNwLP9PSA_v4-ern8kt_fjyfXVbVJIYDJBZCwTmRClVBKHcYVppasCMc85L4cVxNeiRGkVag0WmVYV2MIiTkultRIDcrHrGzf93WPozLIOBTaNdej7YJRWWijJ_xvkkA8zrlkM6l2waH0ILVZm1dZL224MA7O1bRZmK9VspZqtbfPPtllH9Hw_o58usXwH93pj4HIX-FM3uPlwY3M3eohFxJMdXocO12-4bV-NykUuza-7sXnJXm6-waMwz-IvPDycnw</recordid><startdate>200510</startdate><enddate>200510</enddate><creator>CHACKO, BOBBY</creator><creator>JOHN, GEORGE T</creator><creator>NEELAKANTAN, NITHYA</creator><creator>KORULA, ANILA</creator><creator>BALAKRISHNAN, NARASIMHAN</creator><creator>KIRUBAKARAN, MESHACH G</creator><creator>JACOB, CHAKKO K</creator><general>Blackwell Science Pty</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>200510</creationdate><title>Presentation, prognosis and outcome of IgA nephropathy in Indian adults</title><author>CHACKO, BOBBY ; JOHN, GEORGE T ; NEELAKANTAN, NITHYA ; KORULA, ANILA ; BALAKRISHNAN, NARASIMHAN ; KIRUBAKARAN, MESHACH G ; JACOB, CHAKKO K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5015-ee1143433d565e9102bf8fcee7722d9f065ecde5a6e880ae186f0acaeebd68863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Creatinine - metabolism</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Glomerulonephritis, IGA - mortality</topic><topic>Humans</topic><topic>IgA nephropathy</topic><topic>India - epidemiology</topic><topic>Kidney Failure, Chronic - mortality</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Prognosis</topic><topic>progression</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>survival</topic><topic>Survival Rate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CHACKO, BOBBY</creatorcontrib><creatorcontrib>JOHN, GEORGE T</creatorcontrib><creatorcontrib>NEELAKANTAN, NITHYA</creatorcontrib><creatorcontrib>KORULA, ANILA</creatorcontrib><creatorcontrib>BALAKRISHNAN, NARASIMHAN</creatorcontrib><creatorcontrib>KIRUBAKARAN, MESHACH G</creatorcontrib><creatorcontrib>JACOB, CHAKKO K</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Nephrology (Carlton, Vic.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CHACKO, BOBBY</au><au>JOHN, GEORGE T</au><au>NEELAKANTAN, NITHYA</au><au>KORULA, ANILA</au><au>BALAKRISHNAN, NARASIMHAN</au><au>KIRUBAKARAN, MESHACH G</au><au>JACOB, CHAKKO K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Presentation, prognosis and outcome of IgA nephropathy in Indian adults</atitle><jtitle>Nephrology (Carlton, Vic.)</jtitle><addtitle>Nephrology (Carlton)</addtitle><date>2005-10</date><risdate>2005</risdate><volume>10</volume><issue>5</issue><spage>496</spage><epage>503</epage><pages>496-503</pages><issn>1320-5358</issn><eissn>1440-1797</eissn><abstract>Background:  IgA nephropathy (IgAN) is not well characterized in India. This retrospective study of 478 patients with IgAN was performed to clarify the presenting features, prognostic factors and the renal survival rates of the disease. Methods:  Three hundred and forty‐seven patients who had been followed on average for 27 months after diagnosis were divided into two groups based on renal function at diagnosis. In group 1 (229 patients), the creatinine clearance estimated by the Modification of Diet in Renal Disease formula was &lt;85 mL/min and in group 2 (118 patients) it was ≥85 mL/min. Results:  The predominant modes of presentation were nephrotic syndrome, hypertension and renal failure. Twenty‐nine percent of patients had more than a 20% decline in renal function at the last follow up. Multivariate analyses with stepwise logistic regression identified hypertension (odds ratio (OR) 3.5), nephrotic range proteinuria (OR 3.4) and sclerosed glomeruli on biopsy (OR 4.1) to be independently associated with progression in group 1 and hypertension (OR 2.3) in group 2. Seventeen percent of patients progressed to end‐stage renal disease (ESRD). Using multivariate analysis by the Cox model, four risk factors for developing ESRD were identified: hypertension (hazard ratio (HR) 3.1); nephrotic proteinuria (HR 1.9); interstitial fibrosis (HR 2.5); and sclerosed glomeruli (HR 1.8). The renal survival rates at 1, 5 and 10 years were 84, 55 and 33%, respectively, with a median renal survival of 61 months from the time of biopsy. Conclusion:  The relatively rapid rate of progression of IgAN in India is suggestive towards a ‘malignant’ nature of the disease in this country.</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Science Pty</pub><pmid>16221102</pmid><doi>10.1111/j.1440-1797.2005.00445.x</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1320-5358
ispartof Nephrology (Carlton, Vic.), 2005-10, Vol.10 (5), p.496-503
issn 1320-5358
1440-1797
language eng
recordid cdi_proquest_miscellaneous_68683652
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adolescent
Adult
Aged
Creatinine - metabolism
Disease Progression
Female
Follow-Up Studies
Glomerulonephritis, IGA - mortality
Humans
IgA nephropathy
India - epidemiology
Kidney Failure, Chronic - mortality
Logistic Models
Male
Middle Aged
Multivariate Analysis
Prognosis
progression
Retrospective Studies
Risk Factors
survival
Survival Rate
title Presentation, prognosis and outcome of IgA nephropathy in Indian adults
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T03%3A17%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Presentation,%20prognosis%20and%20outcome%20of%20IgA%20nephropathy%20in%20Indian%20adults&rft.jtitle=Nephrology%20(Carlton,%20Vic.)&rft.au=CHACKO,%20BOBBY&rft.date=2005-10&rft.volume=10&rft.issue=5&rft.spage=496&rft.epage=503&rft.pages=496-503&rft.issn=1320-5358&rft.eissn=1440-1797&rft_id=info:doi/10.1111/j.1440-1797.2005.00445.x&rft_dat=%3Cproquest_cross%3E20794281%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20794281&rft_id=info:pmid/16221102&rfr_iscdi=true